1st production QuiremSpheres

On May 21st, the first patient dosis of QuiremSpheres was processed at RTM and then shipped to the stituto Nazionale dei Tumori hospital in Milan, Italy. There it was used for the treatment of a patient suffering from hepatocellular carcinoma (HCC). QuiremSpheres® are radioactive microspheres for SIRT and are based on the isotope holmium-166. 

Voor meer informatie: http://www.quirem.com/

1st production QuiremSpheres

Other news

GMP-certificate received

GMP-certificate received

Today we received our GMP-certificate!The results of the inspection were excellent and no shortcomin...

Read more

RTM added as distributor NeuraCeq®

RTM added as distributor NeuraCeq®

Exciting news! Life Molecular Imaging’s NeuraCeq® 300 MBq/ml solution for injection (florbetaben 18F...

Read more

ABX has received marketing authorisation for the radiotracer Radelumin® in Germany

ABX has received marketing authorisation for the radiotracer Radelumin® in Germany

ABX has received marketing authorisation for the radiotracer Radelumin® in Germany! This marks the 8...

Read more

LinkedIn post Isologic goes electric

LinkedIn post Isologic goes electric

🔌Isologic Goes Electric! We are excited to announce the expansion of our electric fleet with the a...

Read more

Interested in a collaboration?

Contact us to discuss the possibilities.